Measles-mumps-rubella (MMR) vaccine (Daiichi Sankyo)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameMeasles-mumps-rubella (MMR) vaccine (Daiichi Sankyo)
Drug Alias NameMMR-vaccineMeasles-mumps-and-rubella-virus-vaccineMIMRITVN-0102JVC-001
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > Biological material > Bacterial vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaMumpsMeasles
Global Approved IndicationsRubellaMumpsMeasles
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2026/05/11
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcJapan VaccineDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJapan VaccineGlaxosmithkline PlcDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsRubellaMumpsMeasles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A